Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Land & Improvements (2016 - 2024)

Historic Land & Improvements for Angiodynamics (ANGO) over the last 16 years, with Q2 2024 value amounting to $493000.0.

  • Angiodynamics' Land & Improvements changed 0.0% to $493000.0 in Q2 2024 from the same period last year, while for May 2024 it was $493000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $493000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q2 2024, Angiodynamics' Land & Improvements stood at $493000.0, which was down 0.0% from $493000.0 recorded in Q2 2023.
  • Angiodynamics' Land & Improvements' 5-year high stood at $493000.0 during Q2 2022, with a 5-year trough of $472000.0 in Q2 2020.
  • Over the past 5 years, Angiodynamics' median Land & Improvements value was $493000.0 (recorded in 2022), while the average stood at $484600.0.
  • As far as peak fluctuations go, Angiodynamics' Land & Improvements plummeted by 5641.74% in 2020, and later skyrocketed by 444.92% in 2022.
  • Quarter analysis of 5 years shows Angiodynamics' Land & Improvements stood at $472000.0 in 2020, then changed by 0.0% to $472000.0 in 2021, then grew by 4.45% to $493000.0 in 2022, then changed by 0.0% to $493000.0 in 2023, then changed by 0.0% to $493000.0 in 2024.
  • Its Land & Improvements was $493000.0 in Q2 2024, compared to $493000.0 in Q2 2023 and $493000.0 in Q2 2022.